Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-18T02:54:44.509Z Has data issue: false hasContentIssue false

Impact of direct disk-diffusion testing on time to optimal antibiotic therapy

Published online by Cambridge University Press:  27 March 2023

Tulip A. Jhaveri*
Affiliation:
Division of Infectious Diseases, Department of Medicine, University of Mississippi Medical Center, Jackson, MississippiDivision of Medical Microbiology, Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts
Ahmad Taqi
Affiliation:
Department of Pharmacy, Brigham and Women’s Hospital, Boston, MassachusettsDepartment of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, Kuwait
Jeffrey C. Pearson*
Affiliation:
Department of Pharmacy, Brigham and Women’s Hospital, Boston, Massachusetts
Sanjat Kanjilal
Affiliation:
Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, MassachusettsDivision of Infectious Diseases, Brigham and Women’s Hospital, Boston, Massachusetts
*
Author for correspondence: Tulip A. Jhaveri, MBBS, Division of Infectious Diseases, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216. E-mail: tjhaveri@umc.edu. Or Jeffrey C. Pearson, PharmD, Department of Pharmacy, Brigham and Women’s Hospital, 181 Longwood Avenue, Boston, MA 02115. E-mail: jcpearson@bwh.harvard.edu
Author for correspondence: Tulip A. Jhaveri, MBBS, Division of Infectious Diseases, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216. E-mail: tjhaveri@umc.edu. Or Jeffrey C. Pearson, PharmD, Department of Pharmacy, Brigham and Women’s Hospital, 181 Longwood Avenue, Boston, MA 02115. E-mail: jcpearson@bwh.harvard.edu

Abstract

We evaluated the impact of preliminary blood-culture antibiotic susceptibility testing on time to optimal antibiotic therapy in a cohort of 503 patients with monomicrobial bloodstream infections. The median time from blood-culture collection to optimal antibiotics was 17 hours earlier in the preliminary antibiotic susceptibility testing group.

Information

Type
Concise Communication
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Fig. 1.Study flow diagram.

Figure 1

Table 1.Time from Blood Culture Collection to Identification of Species, Reporting of Susceptibilities, and Initiation of Optimal Antibiotic Therapy

Supplementary material: File

Jhaveri et al. supplementary material

Tables S1-S3

Download Jhaveri et al. supplementary material(File)
File 26.2 KB